Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
bioMerieux stock logo
BMXMF
bioMerieux
$142.45
$134.16
$93.50
$143.47
$16.86B0.733 shsN/A
Eurofins Scient stock logo
ERFSF
Eurofins Scient
$71.50
-2.9%
$65.63
$46.36
$73.61
$13.80B0.621,600 shs827 shs
Eisai Co., Ltd. stock logo
ESALY
Eisai
$61.51
-2.1%
$61.51
$36.88
$73.90
$17.64B0.3160,916 shs331,800 shs
Shionogi & Co., Ltd. Unsponsored ADR stock logo
SGIOY
Shionogi & Co., Ltd. Unsponsored ADR
$8.75
-0.5%
$8.31
$6.22
$8.97
$14.89B0.1860,523 shs55,935 shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
bioMerieux stock logo
BMXMF
bioMerieux
0.00%0.00%+6.11%+13.06%+47.62%
Eurofins Scient stock logo
ERFSF
Eurofins Scient
0.00%+1.78%+6.73%+30.06%+46.22%
Eisai Co., Ltd. stock logo
ESALY
Eisai
0.00%0.00%0.00%0.00%0.00%
Shionogi & Co., Ltd. Unsponsored ADR stock logo
SGIOY
Shionogi & Co., Ltd. Unsponsored ADR
0.00%+3.18%+5.68%+16.99%-9.89%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
bioMerieux stock logo
BMXMF
bioMerieux
N/AN/AN/AN/AN/AN/AN/AN/A
Eurofins Scient stock logo
ERFSF
Eurofins Scient
N/AN/AN/AN/AN/AN/AN/AN/A
Eisai Co., Ltd. stock logo
ESALY
Eisai
N/AN/AN/AN/AN/AN/AN/AN/A
Shionogi & Co., Ltd. Unsponsored ADR stock logo
SGIOY
Shionogi & Co., Ltd. Unsponsored ADR
0.6952 of 5 stars
0.03.01.70.02.80.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
bioMerieux stock logo
BMXMF
bioMerieux
3.00
BuyN/AN/A
Eurofins Scient stock logo
ERFSF
Eurofins Scient
2.33
HoldN/AN/A
Eisai Co., Ltd. stock logo
ESALY
Eisai
0.00
N/AN/AN/A
Shionogi & Co., Ltd. Unsponsored ADR stock logo
SGIOY
Shionogi & Co., Ltd. Unsponsored ADR
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest SGIOY, BMXMF, ERFSF, and ESALY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/7/2025
bioMerieux stock logo
BMXMF
bioMerieux
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeModerate Buy ➝ Hold
4/25/2025
Eurofins Scient stock logo
ERFSF
Eurofins Scient
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold
4/25/2025
Eurofins Scient stock logo
ERFSF
Eurofins Scient
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
bioMerieux stock logo
BMXMF
bioMerieux
$4.31B3.91$4.48 per share31.79$38.50 per share3.70
Eurofins Scient stock logo
ERFSF
Eurofins Scient
$7.52B1.83$7.21 per share9.92$30.19 per share2.37
Eisai Co., Ltd. stock logo
ESALY
Eisai
$6.74B2.62$2.68 per share22.94$23.94 per share2.57
Shionogi & Co., Ltd. Unsponsored ADR stock logo
SGIOY
Shionogi & Co., Ltd. Unsponsored ADR
$2.88B5.17$0.74 per share11.84$5.29 per share1.65
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
bioMerieux stock logo
BMXMF
bioMerieux
$467.68MN/A0.00N/AN/AN/AN/A9/4/2025 (Estimated)
Eurofins Scient stock logo
ERFSF
Eurofins Scient
$439.77MN/A0.0018.19N/AN/AN/AN/A7/24/2025 (Estimated)
Eisai Co., Ltd. stock logo
ESALY
Eisai
$426.79M$0.8770.7051.692.464.11%3.86%2.50%N/A
Shionogi & Co., Ltd. Unsponsored ADR stock logo
SGIOY
Shionogi & Co., Ltd. Unsponsored ADR
$1.12BN/A0.0013.462.01N/AN/AN/A7/28/2025 (Estimated)

Latest SGIOY, BMXMF, ERFSF, and ESALY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/12/2025Q4 2025
Shionogi & Co., Ltd. Unsponsored ADR stock logo
SGIOY
Shionogi & Co., Ltd. Unsponsored ADR
$0.1654$0.14-$0.0254$0.14$824.23 million$721.77 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
bioMerieux stock logo
BMXMF
bioMerieux
N/AN/AN/AN/AN/A
Eurofins Scient stock logo
ERFSF
Eurofins Scient
N/AN/AN/AN/AN/A
Eisai Co., Ltd. stock logo
ESALY
Eisai
$0.881.43%N/A101.15%N/A
Shionogi & Co., Ltd. Unsponsored ADR stock logo
SGIOY
Shionogi & Co., Ltd. Unsponsored ADR
$0.151.71%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
bioMerieux stock logo
BMXMF
bioMerieux
0.08
2.20
1.29
Eurofins Scient stock logo
ERFSF
Eurofins Scient
0.58
1.16
1.09
Eisai Co., Ltd. stock logo
ESALY
Eisai
0.10
2.20
1.77
Shionogi & Co., Ltd. Unsponsored ADR stock logo
SGIOY
Shionogi & Co., Ltd. Unsponsored ADR
0.01
6.63
6.13

Institutional Ownership

CompanyInstitutional Ownership
bioMerieux stock logo
BMXMF
bioMerieux
N/A
Eurofins Scient stock logo
ERFSF
Eurofins Scient
N/A
Eisai Co., Ltd. stock logo
ESALY
Eisai
0.03%
Shionogi & Co., Ltd. Unsponsored ADR stock logo
SGIOY
Shionogi & Co., Ltd. Unsponsored ADR
1.92%
CompanyEmployeesShares OutstandingFree FloatOptionable
bioMerieux stock logo
BMXMF
bioMerieux
14,600118.36 millionN/ANot Optionable
Eurofins Scient stock logo
ERFSF
Eurofins Scient
62,696192.98 millionN/ANot Optionable
Eisai Co., Ltd. stock logo
ESALY
Eisai
11,322286.77 millionN/ANot Optionable
Shionogi & Co., Ltd. Unsponsored ADR stock logo
SGIOY
Shionogi & Co., Ltd. Unsponsored ADR
4,9591.70 billionN/ANot Optionable

Recent News About These Companies

Media Sentiment Over Time

bioMerieux stock logo

bioMerieux OTCMKTS:BMXMF

$142.45 0.00 (0.00%)
As of 06/27/2025

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Eurofins Scient stock logo

Eurofins Scient OTCMKTS:ERFSF

$71.50 -2.11 (-2.87%)
As of 06/27/2025 02:38 PM Eastern

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

Eisai stock logo

Eisai OTCMKTS:ESALY

$61.51 -1.33 (-2.11%)
As of 01/30/2023

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

Shionogi & Co., Ltd. Unsponsored ADR stock logo

Shionogi & Co., Ltd. Unsponsored ADR OTCMKTS:SGIOY

$8.75 -0.04 (-0.46%)
As of 06/27/2025 03:59 PM Eastern

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug. It also develops S-872600 an influenza nasal vaccine; S-875670 anCOVID-19 nasal vaccine; S-540956 a nucleic acid adjuvant; S-554110 a nontuberculous mycobacterial infection; S-337395 for RSV infections; S-892216 for COVID-19 therapeutics; Olorofim for invasive aspergillosis; cefiderocol for aerobic gram-negative bacterial infections and infectious diseases; S-268019 a COVID-19 prophylactic vaccine; S-268019 a prophylactic vaccine for COVID-19; ensitrelvir for COVID-19 treatment and prevention; baloxavir for influenza virus infection; S-365598 for HIV infection; and S-555739 for suppressing aggravation of COVID-19. In addition, the company develops S-540956 for nucleic acid adjuvant; S-109802 for post-stroke spasticity; S-151128 for chronic pain; S-588210 and S-531011 for solid tumor; S-309309 for obesity; BPN14770 for Alzheimer's disease and fragile X syndrome; S-588410 for bladder cancer; S-488210 for head and neck squamous cell carcinoma; S-005151 for Acute ischemic stroke and epidermolysis bullosa; Rizmoic for opioid-induced constipation; ADR-001 for decompensated liver cirrhosis; S-222611 for malignant tumor; S-812217 for depression; GRT7039 for pain associated with osteoarthritis of the knee; SDT-001 for inattentive ADHD; S-588410 for esophageal cancer; SR-0379 for cutaneous ulcer; and S-723595 for type 2 diabetes. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.